Glaxosmithkline Share News (GSK)
GSK Share
GSK Share
GSK Share
GSK Share
GSK
GSK Share
GSK Level 2
GSK Live
GSK Broker
GSK Directors
GSK Financial
GSK
GSK Short
GSK
Last checked at -
(Alliance News) - Biopharma firm GSK PLC on Thursday said it will present new data on its ovarian cancer and endometrial cancer drugs from September 9 to 13 at the European Society for Medical Oncology Congress 2022 in Paris.
Read more
(Sharecast News) - Citigroup put pharmaceuticals company GlaxoSmithKline on "positive catalyst watch" on Friday as it pointed to legal developments related to the company's now-discontinued Zantac heartburn drug.
Read more(Alliance News) - The FTSE 100 managed to outperform European counterparts on Friday due to weakness in the pound as consumer confidence in the UK fell to a record low, while attention turns to next week's Jackson Hole Symposium.
Read more(Alliance News) - London's FTSE 100 outperformed peers but was unable to stave off selling pressure in a tough session for European stocks on Friday, despite sitting just above positive territory for much of the late-morning's trade.
Read more(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:
Read more
Aug 17 (Reuters) - The plaintiff in the first lawsuit over the heartburn drug Zantac scheduled to go to trial has agreed to drop his case, according to his attorney and drugmakers named as defendants.
Read moreLONDON, Aug 17 (Reuters) - Shares in GlaxoSmithKline fell slightly in early trading on Wednesday but stayed above recent lows after the plaintiff in the first lawsuit over the heartburn drug Zantac scheduled to go to trial agreed to drop his case.
Read more(Alliance News) - GSK PLC on Wednesday said the US Food & Drug Administration has accepted the new drug application for its momelotinib, which could potentially treat a rare blood cancer myelofibrosis.
Read more(Sharecast News) - The US Food and Drug administration has accepted a new drug application for GlaxoSmithKline's treatment for myelofibrosis patients with anaemia, the company said on Wednesday.
Read more(Sharecast News) - GlaxoSmithKline said the plaintiff in the first lawsuit over the heartburn drug Zantac to go to trial had agreed to drop his case for now.
Read more(Alliance News) - GSK PLC said on Tuesday the first scheduled trial in its Zantac case has been voluntarily dismissed.
Read more(Alliance News) - GSK PLC on Tuesday said it has completed the acquisition of Massachusetts-based clinical-stage biopharmaceutical company Affinivax Inc.
Read moreLONDON, Aug 15 (Reuters) - Britain, the first country to approve a coronavirus vaccine in late 2020, has now also given the first green light to a variant-adapted shot that targets both the original and Omicron version of the virus.
Read moreAug 12 (Reuters) - European shares rose on Friday after drugmakers rebounded following a slump in the previous session, and Flutter fanned a rally in the travel and leisure sector after an upbeat earnings forecast.
Read more
Last checked at